Mollica G, Manno G
Divisione di Gastroenterologia, Ospedale Ferrari, Castrovillari, CZ.
Clin Ter. 1992 Aug;141(8):129-34.
Octylonium bromide (OB) is a drug with spasmolytic properties acting selectively on the smooth muscle of the gastrointestinal tract by interfering with calcium mobilization from extra- and intra-cellular deposits. The etiopathogenetic implications of a psychosomatic nature of the irritable bowel syndrome amply justify the use of a spasmolytic (OB) with a benzodiazepine. In our study, we compared the combination OB + DZ (20 mg + 2 mg) T.I.D. versus OB alone (20 mg) in 30 patients suffering from irritable bowel syndrome. The double-blind study lasting 3 weeks was aimed at evaluating gastrointestinal symptoms (bowel motions, aspect of faeces, abdominal pain, pre-evacuation pain, bloating) during the three days preceding the study and during the last five days of treatment, as well as the anxiogenic situation as assessed by the STAI scale (State Tract Anxiety Inventory) before and at the end of the treatment period. The results obtained showed that both treatments considerably reduced gastrointestinal symptoms even though OB alone did not appear to be equally effective and the anxiety component was significantly reduced only by treatment with the combination. The absence of side effects and the perfect tolerability of both treatments showed the OB + D combination T.I.D. to be the treatment of choice for patients suffering from irritable bowel syndrome.
溴化奥昔布宁(OB)是一种具有解痉特性的药物,它通过干扰细胞外和细胞内钙沉积的钙动员,选择性地作用于胃肠道平滑肌。肠易激综合征心身性质的病因学意义充分证明了使用具有苯二氮䓬类药物的解痉药(OB)的合理性。在我们的研究中,我们比较了30例肠易激综合征患者中OB + 地西泮(20毫克 + 2毫克)每日三次与单独使用OB(20毫克)的情况。这项为期3周的双盲研究旨在评估研究前三天和治疗最后五天的胃肠道症状(排便、粪便外观、腹痛、排便前疼痛、腹胀),以及治疗期开始前和结束时通过状态 - 特质焦虑量表(STAI)评估的焦虑状况。获得的结果表明,两种治疗方法都能显著减轻胃肠道症状,尽管单独使用OB似乎效果不太相同,并且只有联合治疗才能显著减轻焦虑成分。两种治疗方法均无副作用且耐受性良好,表明每日三次的OB + D组合是肠易激综合征患者的首选治疗方法。